Women's Health

The Impact of Time Between Ovarian Cancer Treatments

Specific risk factors

FIGO stage, residual disease, and non-high grade serous carcinoma histology ended up being independent prognostic factors that were shown to offer heightened risks of ovarian cancer progression. Those who had serous carcinoma histology (but at a non-high grade) or residual disease were already placed above the others for how likely they were to die within a shorter period of time. In terms of OS, the multivariate analysis indicated that the length of time between treatments could certainly be an independent prognostic factor in each and every patient.